In May 2020 the United Kingdom Anti-Doping (UKAD) has reported an anti-doping rule violation against the boxer Roseanna Cox after her sample tested positive for the prohibited substancd Furosemide.
After notification the Athlete admitted the violation, waived her right for a hearing, accepted a provisional suspension and the sanction proposed by UKAD.
The Athlete explained that in December 2018 a cyst in her brain was diagnosed which could be fatal when she continues professional boxing. She ended her boxing career and when tested she mistakenly believed that she was not registered anymore with England Boxing. She took the prescribed Furosemide in March 2019 prior to a photoshoot, in connection with her medical condition and her career as a fitness model.
UKAD accepts that the violation was not intentional and that she mistakenly believed she was not subject to and bound by the ADR.
Without grounds for No Significant Fault or Negligence UKAD decides on 22 June 2020 to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 16 May 2019.
